Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), and is prescribed for adult and pediatric patients when indicated.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Products are shipped across multiple regulatory jurisdictions to meet local requirements.

Linezolid is an oxazolidinone antibacterial used to treat infections caused by Gram‑positive bacteria. - Infections caused by susceptible Gram‑positive bacteria: effective eradication of the pathogen and resolution of the infection. - Methicillin‑resistant Staphylococcus aureus (MRSA): provides a therapeutic option when other agents are ineffective. - Vancomycin‑resistant Enterococcus (VRE): used as an alternative treatment for resistant Enterococcus infections.

Linezolid may be associated with a range of adverse reactions, varying from mild gastrointestinal symptoms to potentially life‑threatening events, and patients should be monitored accordingly.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve pain or sensory changes. - Lactic acidosis: metabolic disturbance with high lactate.

When prescribing linezolid, clinicians should consider several safety measures. - Renal impairment: adjust therapy and monitor renal function. - Hepatic impairment: use with caution in patients with liver disease. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Prolonged therapy: monitor complete blood count for myelosuppression. - Pregnancy and lactation: assess risk–benefit before use. - Store at room temperature: keep below 25°C, protect from moisture and light.

Linezolid can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension and serotonin syndrome. - Serotonergic agents (SSRIs, SNRIs, TCAs): may precipitate serotonin syndrome. - Rifampicin: reduces linezolid plasma concentrations, compromising efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may increase anticoagulant effect, monitor INR. - Anticonvulsants (e.g., carbamazepine): may lower linezolid levels. - NSAIDs: potential additive effect on platelet inhibition.